Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

651 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Amelioration of autoimmune nephritis by imatinib in MRL/lpr mice.
Sadanaga A, Nakashima H, Masutani K, Miyake K, Shimizu S, Igawa T, Sugiyama N, Niiro H, Hirakata H, Harada M. Sadanaga A, et al. Among authors: sugiyama n. Arthritis Rheum. 2005 Dec;52(12):3987-96. doi: 10.1002/art.21424. Arthritis Rheum. 2005. PMID: 16320345 Free article.
Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice.
Sadanaga A, Nakashima H, Akahoshi M, Masutani K, Miyake K, Igawa T, Sugiyama N, Niiro H, Harada M. Sadanaga A, et al. Among authors: sugiyama n. Arthritis Rheum. 2007 May;56(5):1618-28. doi: 10.1002/art.22571. Arthritis Rheum. 2007. PMID: 17469144 Free article.
Efficacy and safety of tofacitinib for the treatment of rheumatoid arthritis in patients from the Asia-Pacific region: Post-hoc analyses of pooled clinical study data.
Lee EB, Yamanaka H, Liu Y, Tsai WC, Chen C, Kwok K, Yoo HJ, Llamado LJ, Wang L, Luo Y, Sugiyama N, Tanaka Y. Lee EB, et al. Among authors: sugiyama n. Int J Rheum Dis. 2019 Jun;22(6):1094-1106. doi: 10.1111/1756-185X.13516. Epub 2019 Mar 22. Int J Rheum Dis. 2019. PMID: 30900375 Free PMC article.
Efficacy and safety of tofacitinib in Japanese patients with rheumatoid arthritis by background methotrexate dose: A post hoc analysis of clinical trial data.
Takeuchi T, Yamanaka H, Yamaoka K, Arai S, Toyoizumi S, DeMasi R, Fukuma Y, Hirose T, Sugiyama N, Zwillich SH, Tanaka Y. Takeuchi T, et al. Among authors: sugiyama n. Mod Rheumatol. 2019 Sep;29(5):756-766. doi: 10.1080/14397595.2018.1553489. Epub 2019 Jan 11. Mod Rheumatol. 2019. PMID: 30489177 Free article. Clinical Trial.
651 results